跳至主要内容
临床试验/NCT03602209
NCT03602209已完成不适用

Short vs. Long Antibiotic Treatment of Implant-free Osteoarticular Infections

University Hospital, Geneva1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2015年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Remission of infection

研究概览

简要总结

The investigators tested the working hypothesis if 4 weeks of systemic antibiotic treatment in implant-related orthopaedic infections is non-inferior to 6 weeks after complete removal of the infected implant. Randomization 1:1.

The study is completed. It halted prematurely and will not resume; participants are no longer being examined or receiving intervention.

详细描述

Former description of the study (now completed)

Osteoarticular infections related to orthopaedic implants are associated with substantial morbidity, prolongation of hospital stay, and additional costs. Due to the increasing number of patients with orthopaedic implants in Switzerland, similar to the rest of Europe and elsewhere, the number of infections is expected to increase. While the surgical treatment of these infections has been well studied, the ideal duration of antibiotic therapy after removal (explantation) of the infected implant remains unknown. For almost 40 years, the recommended total duration of post-explantation antibiotic therapy has been 6 weeks. This recommendation is based on expert's personal experience rather than on prospective randomized studies. Shorter treatment would decrease antibiotic-related adverse events and costs hospital stay for patients awaiting an eventual reinsertion of a new implant. If physicians and surgeon prescribe antibiotics for 6 weeks, this duration should be at least supported by evidence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (≥17 years old)
  • Total removal of the implant

排除标准

  • Primary native joint septic arthritis;
  • Co-trimoxazole prophylaxis because of immunosuppression;
  • Left-side endocarditis;
  • Persistent implant material in the infected area.
  • Infections with tuberculosis; mycobacteria; fungi; brucellosis; borreliosis; nocardiosis; and mycoplasmal osteosynthesis infections

研究组 & 干预措施

4 weeks of treatment

Experimental

干预措施: Removal of infected implant (Procedure)

4 weeks of treatment

Experimental

干预措施: Antibiotic durations (Drug)

6 weeks of treatment

Active Comparator

干预措施: Removal of infected implant (Procedure)

6 weeks of treatment

Active Comparator

干预措施: Antibiotic durations (Drug)

结局指标

主要结局

Remission of infection

时间窗: 12 months

Clinical evaluation

Adverse events

时间窗: 12 months

Clinical adverse events

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ilker Uckay

Attending, Docent Dr. med. Ilker Uçkay

University Hospital, Geneva

研究点 (1)

Loading locations...

相似试验

Short vs. Long Antibiotic Treatment of Implant-free... | 临床试验